NCT04846075

Brief Summary

This observational study collects data on blood neurotransmitter and neuromodulator levels of subjects observing Ramadan. Additional information collected are a diet record, mood and perceived stress using validated surveys at three time points: a) before starting Ramadan, b) at the midpoint evaluation, and c) at the end of Ramadan. Three additional dispositional factors collected at the beginning and at the end are: a) sense of belonging, b) purpose in life (sense of coherence), and c) empathy (interpersonal reactivity index). The subjects are also individually interviewed on their experience of Ramadan as narrative data.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2021

Completed
Same day until next milestone

Study Start

First participant enrolled

April 8, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 15, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
Last Updated

April 15, 2021

Status Verified

April 1, 2021

Enrollment Period

1 month

First QC Date

April 8, 2021

Last Update Submit

April 13, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in dopamine concentration

    Plasma dopamine level pg/mL

    0 to 30 days

  • Change in serotonin concentration

    Plasma serotonin level ng/mL

    0 to 30 days

  • Change in Brain-Derived Neurotrophic factor (BDNF) concentration

    Plasma BDNF level pg/mL

    0 to 30 days

  • Change in Nerve Growth Factor (NGF) concentration

    Plasma NGF level pg/mL

    0 to 30 days

Secondary Outcomes (2)

  • Change in mood measured by Positive And Negative Affect Scale (PANAS)

    0 to 30 days

  • Change in perceived stress level measured by Weekly Stress Inventory (WSI)

    0 to 30 days

Study Arms (1)

Ramadan Group

Diurnal fasting and spiritual practices. Operationally assessed by the level of compliance to Sawm, Salat, and Zakat.

Behavioral: Ramadan fasting, praying, and welfare for poor

Interventions

Abstaining from food, drink, smoking, and sexual activity duirng daytime; ritualistic praying at specific time of a day for five or more times; volunteering for communities or donation

Also known as: Diurnal fasting or Sawm; five or more prayers or Salat; donation or volunteering or Zakat
Ramadan Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Upon obtaining permission from the community leaders (Muslim Association of Puget Sound) and support from IMAN Center of Kirkland, flyers will be disseminated through friends and family members of Muslim members. Anyone who observes Ramadan for religious or health reasons, and who are also committed to following the fasting as prescribed, and who do not have chronic health conditions, will be eligible for participation in this study.

You may qualify if:

  • Male or female ≥ 18 years of age at the time of baseline blood draw, up to 65 years old
  • Community member who observe Ramadan during April 12 (Monday evening) through May 11, 2021 (Tuesday sundown)
  • Understand and sign the informed consent form and have ability to comply with the requiremnets of the study
  • Vaccinated for COVID or having a history of a positive PCR test which was resolved

You may not qualify if:

  • Anticubital vein is not accessible
  • Pregnant, breastfeeding, recovering from major illness or surgery that influences quality of life
  • Who reside more than 14 miles away from the city limits
  • Unavailable to meet in-person and donate blood for any of three measurement days (basline, 15th day, post Ramadan)
  • Smoking, drinking aclohol or using recreational drug
  • Presence of a condition that in the opinon of the Investigator would compromise the safety of the participant or the quality of the data

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bastyr University

Kenmore, Washington, 98028, United States

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

10 mL serum (SST) and 10 mL (plasma) EDTA

MeSH Terms

Interventions

phosphoribosylanthranilate isomeraseSocial WorkPoverty

Intervention Hierarchy (Ancestors)

Health ServicesHealth Care Facilities Workforce and ServicesSocioeconomic FactorsPopulation Characteristics

Study Officials

  • Masa Sasagawa, ND, PhD

    Bastyr University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Masa Sasagawa, ND, PhD

CONTACT

Paul Amieux, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Research Scientist

Study Record Dates

First Submitted

April 8, 2021

First Posted

April 15, 2021

Study Start

April 8, 2021

Primary Completion

May 15, 2021

Study Completion

June 30, 2021

Last Updated

April 15, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Data are collected by subject IDs (SIDs). Only aggregate results will be available

Locations